170 related articles for article (PubMed ID: 22492660)
21. Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort.
Karim ME; Gustafson P; Petkau J; Zhao Y; Shirani A; Kingwell E; Evans C; van der Kop M; Oger J; Tremlett H
Am J Epidemiol; 2014 Jul; 180(2):160-71. PubMed ID: 24939980
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal plasmode algorithms to evaluate statistical methods in realistic scenarios: an illustration applied to occupational epidemiology.
Souli Y; Trudel X; Diop A; Brisson C; Talbot D
BMC Med Res Methodol; 2023 Oct; 23(1):242. PubMed ID: 37853309
[TBL] [Abstract][Full Text] [Related]
23. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
[TBL] [Abstract][Full Text] [Related]
24. Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination.
Lusivika-Nzinga C; Selinger-Leneman H; Grabar S; Costagliola D; Carrat F
BMC Med Res Methodol; 2017 Dec; 17(1):160. PubMed ID: 29202691
[TBL] [Abstract][Full Text] [Related]
25. Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study.
Patson N; Mukaka M; Kazembe L; Eijkemans MJC; Mathanga D; Laufer MK; Chirwa T
BMC Med Res Methodol; 2022 Jan; 22(1):24. PubMed ID: 35057743
[TBL] [Abstract][Full Text] [Related]
26. Constructing inverse probability weights for marginal structural models.
Cole SR; Hernán MA
Am J Epidemiol; 2008 Sep; 168(6):656-64. PubMed ID: 18682488
[TBL] [Abstract][Full Text] [Related]
27. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
Filges T; Sonne-Schmidt CS; Nielsen BCV
Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
[TBL] [Abstract][Full Text] [Related]
28. Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: a simulation study.
Chu R; Thabane L; Ma J; Holbrook A; Pullenayegum E; Devereaux PJ
BMC Med Res Methodol; 2011 Feb; 11():21. PubMed ID: 21338524
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.
Heng F; Sun Y; Hyun S; Gilbert PB
Lifetime Data Anal; 2020 Oct; 26(4):731-760. PubMed ID: 32274677
[TBL] [Abstract][Full Text] [Related]
30. [Marginal structural models application to estimate the effects of antiretroviral therapy in 5 cohorts of HIV seroconverters].
Pérez-Hoyos S; Ferreros I; Hernán MA;
Gac Sanit; 2007; 21(1):76-83. PubMed ID: 17306191
[TBL] [Abstract][Full Text] [Related]
31. Learning from local to global: An efficient distributed algorithm for modeling time-to-event data.
Duan R; Luo C; Schuemie MJ; Tong J; Liang CJ; Chang HH; Boland MR; Bian J; Xu H; Holmes JH; Forrest CB; Morton SC; Berlin JA; Moore JH; Mahoney KB; Chen Y
J Am Med Inform Assoc; 2020 Jul; 27(7):1028-1036. PubMed ID: 32626900
[TBL] [Abstract][Full Text] [Related]
32. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
33. Time-modified confounding.
Platt RW; Schisterman EF; Cole SR
Am J Epidemiol; 2009 Sep; 170(6):687-94. PubMed ID: 19675141
[TBL] [Abstract][Full Text] [Related]
34. Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.
Karim ME; Petkau J; Gustafson P; Platt RW; Tremlett H;
Stat Methods Med Res; 2018 Jun; 27(6):1709-1722. PubMed ID: 27659168
[TBL] [Abstract][Full Text] [Related]
35. Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study.
Young JG; Vatsa R; Murray EJ; Hernán MA
Trials; 2019 Sep; 20(1):552. PubMed ID: 31488202
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation.
Schomaker M; Hogger S; Johnson LF; Hoffmann CJ; Bärnighausen T; Heumann C
Epidemiology; 2015 Sep; 26(5):628-36. PubMed ID: 26214336
[TBL] [Abstract][Full Text] [Related]
37. Bias Reduction through Analysis of Competing Events (BRACE) Correction to Address Cancer Treatment Selection Bias in Observational Data.
Williamson CW; Nelson TJ; Thompson CA; Vitzthum LK; Zakeri K; Riviere PJ; Bryant AK; Sharabi AB; Zou J; Mell LK
Clin Cancer Res; 2022 May; 28(9):1832-1840. PubMed ID: 35140122
[TBL] [Abstract][Full Text] [Related]
38. Comparison of methods for estimating the attributable risk in the context of survival analysis.
Gassama M; Bénichou J; Dartois L; Thiébaut AC
BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
[TBL] [Abstract][Full Text] [Related]
39. The impact of unmeasured baseline effect modification on estimates from an inverse probability of treatment weighted logistic model.
Delaney JA; Platt RW; Suissa S
Eur J Epidemiol; 2009; 24(7):343-9. PubMed ID: 19418232
[TBL] [Abstract][Full Text] [Related]
40. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
Boyd AP; Kittelson JM; Gillen DL
Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
